FolioLanternBeta
CVSCVS Health

Tilak Mandadi

EVP, Chief Exp & Tech Officer at CVS Health, as of May 11, 2026Sold $6.2M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
10K
shares held after the latest filing, CVS Health
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
70K
shares sold, past 12 months
1
days with sales
$6.2M
largest single day, May 8, 2026
2
companies filed for

Share of stake sold at CVS Health is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMay 2026: $6.2M no plan disclosed$6.2MMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
CVS Health (CVS)EVP, Chief Exp & Tech OfficerSep 2, 2022May 11, 2026
MGM Resorts (MGM)Former CsitoAug 4, 2021Jun 17, 2022

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.